Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

One English pound placed on a graph to represent an economic down turn
Investing Articles

Could an S&P 500 crash hit the FTSE 100? Here’s what the experts think…

| Mark Hartley

Mark Hartley explores how a potential S&P 500 crash could impact the FTSE 100 -- and one major strategy shift…

Read more »

Mature people enjoying time together during road trip
Investing Articles

‘FTSE 100 to reach 10,172!’ What are the best stocks to consider buying before the surge?

| Zaven Boyrazian, CFA

Updated analyst forecasts predict more growth’s on the horizon for the UK's flagship index. But which stocks could benefit from…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

How realistic is this FTSE 100 growth stock’s ambitious 5-year plan?

| John Fieldsend

One of the biggest FTSE 100 names has its eyes on spectacular growth over the next five years. Is this…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Be ready for a stock market crash in 2026

| Ben McPoland

More chief executives and people on Wall Street are concerned that the stock market is currently in an artificial intelligence-inflated…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

History suggests FTSE 100 stocks will do this if the US stock market crashes

| Zaven Boyrazian, CFA

The risk of a sharp downturn among US stocks is on the rise, according to some experts, but what does…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Up 15% and 10% in a week! Are these 2 UK growth and income stocks about to go gangbusters?

| Harvey Jones

Harvey Jones looks over two FTSE 100 income stocks that have had a bumpy time of it lately, but are…

Read more »

Investing Articles

Set to go up 57%? Here are the latest share price forecasts for AstraZeneca

| John Fieldsend

The share price forecasts for Astrazeneca are looking very bullish indeed. Here's a round up of what analysts are expecting…

Read more »

ISA Individual Savings Account
Investing Articles

I asked ChatGPT for 3 FTSE 100 picks for a Stocks and Shares ISA. Here’s what it said

| Alan Oscroft

Thinking of starting a new Stocks and Shares ISA? It's worth seeking a range of opinions, but be sure to…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

At 217%, the ‘Warren Buffett indicator’ is higher than during the dotcom bubble! Is a crash coming?

| John Fieldsend

The Warren Buffett indicator has risen to fresh record highs. Is this a sign that a crash might be heading…

Read more »

US Tariffs street sign
Investing Articles

Is a 15% stock market correction coming? If so, I’m ready

| Mark Hartley

With experts voicing concerns, our writer outlines his defensive plan in the event a forecast stock market correction becomes reality.

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The FTSE 100’s largest company could surpass a £200bn market valuation this year

| Dr. James Fox

AstraZeneca is the largest company on the FTSE 100, and it could soon have a more-than-£200bn valuation as the market’s…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Just over £119 now, AstraZeneca’s share price looks cheap to me anywhere under £220.91

| Simon Watkins

AstraZeneca’s share price has fallen since its September one-year high, which indicates that it could be a bargain. I ran…

Read more »